CAS 100324-80-9

Formel: C13H20N4O3

InChl: InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m0/s1

InChI Key: NSMXQKNUPPXBRG-VIFPVBQESA-N

SMILES: C[C@@H](CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O

(S)-Lisofylline

CAS: 100324-80-9

(S)-Lisofylline

Formel: C₁₃H₂₀N₄O₃

Reinheit: ≥98%

Molekulargewicht: 280.32

Ref: 54-BUP22003

(S)-Lisofylline

CAS: 100324-80-9

Reinheit: 99%

Ref: IN-DA008SQU

(S)-Lisofylline

CAS: 100324-80-9

(S)-Lisofylline, an inactive enantiomer of (R)-lisofylline, turns into pentoxifylline in human liver.

Formel: C₁₃H₂₀N₄O₃

Reinheit: 99.61%

Farbe und Form: Solid

Molekulargewicht: 280.32

Ref: TM-T22148

3,7-Dihydro-1-(5S-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione

Kontrolliertes Produkt

CAS: 100324-80-9

3,7-Dihydro-1-(5S-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione is a chiral compound that can be used as a precursor for the synthesis of pharmaceuticals. It can be obtained by reacting vinyl acetate with an enantiomerically pure form of 3,7-dihydro-1-(5R)-hydroxyhexyl)-3,7-dimethyl-1H purine 2,6(3H) dione. This reaction is catalyzed by immobilized lipase and the yield depends on the parameters used. The single crystal x ray diffraction technique has been used to investigate the structure of this compound.

Formel: C₁₃H₂₀N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 280.32 g/mol

Ref: 3D-AEA32480